CA41465-7 - 0x000000000000643F
Males & Females of Non-Childbearing Potential
Ginger
* Stipend may pay up to reflected amount.
Start Date:
April 30, 2025 - 10:45am
End Date:
May 30, 2025 - 10:00am
Study Details
Study Number: CA41465
Group Number: 7
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,000.00
Study Criteria
Age: 18 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat nausea and vomiting.
Route of Administration: Injection subcutaneous
Blood Draws: 23
Study Schedule
Schedule Type: Short stays with returns
Study Length: 6 Night Stay & 3 Returns
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 4/28/2025 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Monday | 4/28/2025 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Wednesday | 4/30/2025 10:45:00 AM | Tuesday | 5/6/2025 10:15:00 AM | 1 | Phoenix |
| Return | Friday | 5/9/2025 9:00:00 AM | Friday | 5/9/2025 10:00:00 AM | 1 | Phoenix |
| Return | Thursday | 5/15/2025 9:00:00 AM | Thursday | 5/15/2025 10:00:00 AM | 1 | Phoenix |
| Return | Friday | 5/30/2025 9:00:00 AM | Friday | 5/30/2025 10:00:00 AM | 1 | Phoenix |
